No Increase in Chronic Pain Among Opioid-Dependent Individuals Randomized to Treatment With Extended-Release Naltrexone Compared to Buprenorphine-Naloxone

被引：1
|
作者：
Tanum, Lars [1 ]
Latif, Zill-E-Huma [1 ]
Solli, Kristin [1 ]
Opheim, Arild [2 ]
Kunoe, Nikolaj [3 ]
Benth, Jurate [3 ]
Krajci, Peter [4 ]
机构：
[1] Akershus Univ Hosp, Nordbyhagen, Norway
[2] Haukeland Hosp, Bergen, Norway
[3] Univ Oslo, Oslo, Norway
[4] Oslo Univ Hosp, Oslo, Norway
来源：
BIOLOGICAL PSYCHIATRY | 2019年 / 85卷 / 10期
关键词：
Opioid Use Disorder; Long-Acting Naltrexone; Chronic Pain; Buprenorphine;
D O I：
10.1016/j.biopsych.2019.03.535
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T212
引用
收藏
页码：S211 / S212
页数：2
相关论文
共 50 条
  • [31] Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
    Lee, Joshua D.
    Malone, Mia
    McDonald, Ryan
    Cheng, Anna
    Vasudevan, Kumar
    Tofighi, Babak
    Garment, Ann
    Porter, Barbara
    Goldfeld, Keith S.
    Matteo, Michael
    Mangat, Jasdeep
    Katyal, Monica
    Giftos, Jonathan
    MacDonald, Ross
    JAMA NETWORK OPEN, 2021, 4 (09)
  • [32] A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and Probationers
    Coviello, Donna M.
    Cornish, James W.
    Lynch, Kevin G.
    Boney, Tamara Y.
    Clark, Cynthia A.
    Lee, Joshua D.
    Friedmann, Peter D.
    Nunes, Edward V.
    Kinlock, Timothy W.
    Gordon, Michael S.
    Schwartz, Robert P.
    Nuwayser, Elie S.
    O'Brien, Charles P.
    SUBSTANCE ABUSE, 2012, 33 (01) : 48 - 59
  • [33] Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone
    Karlsson, Ann Tarja
    Vederhus, John-Kare
    Clausen, Thomas
    Weimand, Bente
    Solli, Kristin Klemmetsby
    Tanum, Lars
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (18)
  • [34] Buprenorphine-Naloxone vs. Extended-Release Naltrexone for Opioid Use Disorder in People With Recent Criminal Legal Involvement: A Secondary Analysis of the X:BOT Randomized Controlled Trial
    Balter, Dylan
    Puglisi, Lisa
    Dziura, James
    Fiellin, David
    Howell, Benjamin
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [35] Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
    Ross, Rachael K.
    Nunes, Edward V.
    Olfson, Mark
    Shulman, Matisyahu
    Krawczyk, Noa
    Stuart, Elizabeth A.
    Rudolph, Kara E.
    ADDICTION, 2024, 119 (11) : 1975 - 1986
  • [36] Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
    Jackson, Heide
    Mandell, Kara
    Johnson, Kimberly
    Chatterjee, Debanjana
    Vanness, David J.
    SUBSTANCE ABUSE, 2015, 36 (02) : 226 - 231
  • [37] Optimal Prevention of Relapse Among Opioid Users: A 12-Week Randomized Controlled Trial of Extended- Release Naltrexone Injections Versus Daily Buprenorphine-Naloxone
    Tanum, Lars
    Solli, Kristin
    Opheim, Arild
    Sharma-Haase, Kamni
    Latif, Huma
    Kunoe, Nikolaj
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S265 - S266
  • [38] Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
    Lee, Joshua D.
    Nunes, Edward V., Jr.
    Novo, Patricia
    Bachrach, Ken
    Bailey, Genie L.
    Bhatt, Snehal
    Farkas, Sarah
    Fishman, Marc
    Gauthier, Phoebe
    Hodgkins, Candace C.
    King, Jacquie
    Lindblad, Robert
    Liu, David
    Matthews, Abigail G.
    May, Jeanine
    Peavy, K. Michelle
    Ross, Stephen
    Salazar, Dagmar
    Schkolnik, Paul
    Shmueli-Blumberg, Dikla
    Stablein, Don
    Subramaniam, Geetha
    Rotrosen, John
    LANCET, 2018, 391 (10118): : 309 - 318
  • [39] Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study
    Barry, Declan T.
    Savant, Jonathan D.
    Beitel, Mark
    Cutter, Christopher J.
    Moore, Brent A.
    Schottenfeld, Richard S.
    Fiellin, David A.
    AMERICAN JOURNAL ON ADDICTIONS, 2013, 22 (03): : 212 - 217
  • [40] Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone
    Tsui, Judith I.
    Campbell, Aimee N. C.
    Pavlicova, Martina
    Choo, Tse-Hwei
    Lee, Joshua D.
    Cook, Ryan R.
    Shulman, Matisyahu
    Nunes, Edward, V
    Rotrosen, John
    DRUG AND ALCOHOL DEPENDENCE, 2022, 236
12345